KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to $79.0 million.

  • Biolife Solutions' Cash & Current Investments rose 13094.07% to $79.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $79.0 million, marking a year-over-year increase of 13094.07%. This contributed to the annual value of $104.6 million for FY2024, which is 13670.11% up from last year.
  • Latest data reveals that Biolife Solutions reported Cash & Current Investments of $79.0 million as of Q3 2025, which was up 13094.07% from $81.8 million recorded in Q2 2025.
  • Biolife Solutions' 5-year Cash & Current Investments high stood at $104.6 million for Q4 2024, and its period low was $34.1 million during Q2 2024.
  • Over the past 5 years, Biolife Solutions' median Cash & Current Investments value was $61.6 million (recorded in 2022), while the average stood at $62.9 million.
  • In the last 5 years, Biolife Solutions' Cash & Current Investments surged by 129164.06% in 2021 and then tumbled by 3899.4% in 2022.
  • Over the past 5 years, Biolife Solutions' Cash & Current Investments (Quarter) stood at $69.9 million in 2021, then decreased by 10.26% to $62.7 million in 2022, then decreased by 29.53% to $44.2 million in 2023, then skyrocketed by 136.7% to $104.6 million in 2024, then fell by 24.51% to $79.0 million in 2025.
  • Its Cash & Current Investments stands at $79.0 million for Q3 2025, versus $81.8 million for Q2 2025 and $88.6 million for Q1 2025.